Description
Patented medical device.
Topical therapy of all trophic-dyschromic alterations of the dermal tissue epidermal.
Post-operative bruising and hematomas (post blepharoplasty, etc.), post-sclerotherapy haemosiderin discolouration, prevention of iron-dependent venous ulcers, varicose ulcers, bedsores, fissures, burns, delayed wound healing, therapy post laser (epilation, ablative and non-ablative).

Mode instructions for use
Every time you apply the cream it is It is necessary to cleanse the affected area with physiological solution. The quantity and number of applications varies depending on the clinical conditions of the lesions and the absorption time of the cream. However, at least two applications per day are recommended.

Components
Polyethylene glycol 400, polyethylene glycol 1,500, polyethylene glycol 4,000, lactoferrin LT (Lipid Technology), sorbitol, glycerol, allantoin, tocopherol.

Warnings
Do not use if the packaging is not correct. intact. External use.
The simultaneous use of creams and/or similar on the same anatomical part can cause preclude the effectiveness and safety of the device. After use, do not dispose of the product in the environment. Keep the product out of the reach of children. Do not swallow. In case of accidental ingestion, consult your doctor. Do not use beyond the expiry date.

Storage
Store the package tightly closed at a temperature not exceeding 25 °C in a dry place, protected from light and sources of heat.

Format
5 sterile single-dose applicators of 5 ml.

Code 5010075